CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 135 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2020. The put-call ratio across all filers is 0.02 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $12,040,000 | +51.9% | 356,234 | +5.1% | 0.00% | +100.0% |
| Q1 2021 | $7,925,000 | -22.7% | 338,829 | -4.8% | 0.00% | -50.0% |
| Q4 2020 | $10,248,000 | +39.4% | 355,904 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $7,350,000 | -26.2% | 362,771 | +9.5% | 0.00% | 0.0% |
| Q2 2020 | $9,954,000 | +36.7% | 331,241 | +43.0% | 0.00% | 0.0% |
| Q1 2020 | $7,283,000 | -15.0% | 231,717 | +27.4% | 0.00% | 0.0% |
| Q4 2019 | $8,568,000 | +753.4% | 181,873 | +16.9% | 0.00% | – |
| Q3 2019 | $1,004,000 | -44.1% | 155,528 | +6.3% | 0.00% | – |
| Q2 2019 | $1,797,000 | +2.2% | 146,358 | +12.7% | 0.00% | – |
| Q1 2019 | $1,759,000 | +762.3% | 129,810 | +154.5% | 0.00% | – |
| Q4 2018 | $204,000 | -33.3% | 51,008 | +12.4% | 0.00% | – |
| Q3 2018 | $306,000 | – | 45,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |